Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | MITF | O75030 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.49 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MLNR | O43193 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL288736 | 1.00 | FDPS (0.52) | FDPSKMT2AMEN1LMNATP53 | |
| SCHEMBL5782951 | 1.00 | FDPS (0.52) | FDPSKMT2AMEN1LMNATP53 | |
| SCHEMBL5499053 | 0.98 | KMT2A (0.51) | FDPSKMT2AMEN1LMNATP53 | |
| Hydrochloric Acid SCHEMBL16909535 | 0.98 | FDPS (0.50) | FDPSKMT2AMEN1LMNATP53 | |
| Hydrochloric Acid SCHEMBL645809 | 0.98 | FDPS (0.50) | FDPSKMT2AMEN1LMNATP53 | |
| Hydrochloric Acid SCHEMBL16909729 | 0.98 | FDPS (0.50) | FDPSKMT2AMEN1LMNATP53 | |
| Oxalic Acid SCHEMBL28807941 | 0.96 | FDPS (0.49) | FDPSKMT2AMEN1LMNATP53 | |
| SCHEMBL288786 | 0.93 | — | — | |
| SCHEMBL1476244 | 0.93 | — | — | |
| SCHEMBL288677 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119330874-A | Parsley alkaloid, hybridoma cell strain, antibody and application | 江南大学 | 2025-01-21 | — | — | CN | claimed |
| CN-112566900-B | Immunomodulator, composition and preparation method thereof | 贝达药业股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-112424194-B | Immunomodulator, composition and preparation method thereof | 贝达药业股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-117050061-A | 2,4, 6-tri (piperidinecarboxylic acid) -1,3,5 triazine and preparation method thereof | 济南利恒生物科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-113603886-A | Polyethyleneimine derivative and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2021-11-05 | — | — | CN | claimed |
| CN-102216279-B | Phenyl pyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof | TOPHARMAN SHANGHAI Co.,Ltd. (CN) | 2014-10-29 | — | — | CN | claimed |
| CN-100508975-C | Use of pyrazolopyridine compound | ASTELLAS PHARMA INC (JP) | 2009-07-08 | — | — | CN | claimed |
| US-20050075270-A1 | Process for preparation of piperidin-2-ylacetic acid | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-04-07 | — | — | US | claimed |
| EP-1426359-A1 | PROCESS FOR PREPARATION OF PIPERIDIN-2-YLACETIC ACID | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-09 | — | — | EP | claimed |
| JP-8333339-A | — | — | None | — | — | JP | disclosed |
| EP-4731266-A1 | NANOPARTICLE COMPOSITIONS ASSOCIATED WITH PEPTIDES | The Regents of the University of Michigan (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260108618-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2026-04-23 | — | — | US | disclosed |
| US-12600909-B2 | Etching solution composition | RASA INDUSTRIES, LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| US-12569565-B2 | Compositions and methods for the treatment of viral infections | CIDARA THERAPEUTICS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| EP-0497258-A2 | Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-08-05 | — | — | EP | disclosed |
| US-4943635-A | OXAZABOROLIDINES AND OXAZABORINES AS CATALYSTS | PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) | 1990-07-24 | — | — | US | disclosed |
| EP-0305180-A2 | Enantioselective reduction of ketones | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1989-03-01 | — | — | EP | disclosed |
| US-4402961-A | Derivatives of 1-(2-,3- or 4-quinolyl)-2- or -3-(2- or 3-piperidyl or -pyrrolidinyl) ethanone or propanone, and their utilization as antiarrhythmics, anticonvulsivants and for the treatment of anxiety | PHARMINDUSTRIE (FR) | 1983-09-06 | — | — | US | disclosed |
| US-4217238-A | BASIC SALT, SCRUBBING | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-08-12 | — | — | US | disclosed |
| US-4094957-A | CARBON DIOXIDE | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108618-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | FCGR3B, FCGR1A, FCGR2A | FDPS 4033/4885KMT2A 1692/4885MEN1 4679/4885 |
| US-12569565-B2 | Compositions and methods for the treatment of viral infections | ALB, FCGR3B, FCGR1A | FDPS 3656/4885KMT2A 1639/4885MEN1 3799/4885 |
| US-12600909-B2 | Etching solution composition | ASIC3, GRIN2D, ASIC1 | FDPS 2037/4885KMT2A 1013/4885MEN1 3125/4885 |
| US-20050075270-A1 | Process for preparation of piperidin-2-ylacetic acid | CIP2A, TPH2, TET2 | FDPS 4590/4885KMT2A 24/4885MEN1 4393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.